| Abstrakt: |
This patent application by Biogen MA Inc. discusses methods and systems for classifying brain lesions and predicting their development, with a specific focus on multiple sclerosis (MS). The application addresses the challenges of diagnosing and monitoring MS, which currently rely on radiologists' judgment and multiple MRI scans. The disclosed methods involve using machine learning and biomarkers to classify and predict the progression of brain lesions based on single-point imaging. These methods aim to improve the diagnosis, monitoring, and treatment of MS. The patent application was filed by a group of inventors and is not limited to the described methods. [Extracted from the article] |
